BCP ALL
Showing 1 - 25 of >10,000
Acute Lymphoblastic Leukemia Trial in Bergamo, Monza (PTG-CARCIK-CD19)
Recruiting
- Acute Lymphoblastic Leukemia
- PTG-CARCIK-CD19
-
Bergamo, Italy
- +1 more
Feb 12, 2022
ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)
Recruiting
- ALL, Recurrent, Adult
-
Frankfurt (Main), Hessen, Germany
- +1 more
Jan 6, 2022
B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Blinatumomab
- Conventional therapy
-
Suzhou, Jiangsu, ChinaThe first affiliated hospital of Soochow University
Sep 26, 2022
BD OneFlow Acute Leukemia Panel on BD FACSLyric Flow Cytometer
Recruiting
- Acute Leukemia
- IUO Acute Leukemia Panel
-
Los Angeles, California
- +6 more
Jul 15, 2022
Acute Lymphoblastic Leukemia, Adult B-Cell Trial in Paris (Blinatumomab Injection)
Active, not recruiting
- Acute Lymphoblastic Leukemia, Adult B-Cell
- Blinatumomab Injection
-
Paris, FranceHopital saint Louis
Apr 30, 2021
B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia
- (no location specified)
Oct 10, 2023
ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)
Not yet recruiting
- ACUTE LYMPHOBLASTIC LEUKEMIA
- Inotuzumab ozogamicin
- ALLR3
- (no location specified)
Feb 17, 2023
Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP) Trial in France
Unknown status
- Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)
- Inotuzumab ozogamicin (INO)
-
Amiens, France
- +34 more
Aug 10, 2020
SARS-CoV2 Infection, COVID-19 Trial in Long Beach, Miami Lakes, New York (IMM-BCP-01, Placebo)
Recruiting
- SARS-CoV2 Infection
- COVID-19
- IMM-BCP-01
- Placebo
-
Long Beach, California
- +2 more
Aug 11, 2022
Beta-Caryophyllene Trial in Hartford (Low Dose Beta-Caryophyllene, Medium Dose Beta-Caryophyllene, High Dose Beta-Caryophyllene)
Withdrawn
- Beta-Caryophyllene
- Low Dose Beta-Caryophyllene
- +3 more
-
Hartford, ConnecticutHartford Hospital
Oct 26, 2021
Alveolar Ridge Enlargement, Fenestration, Dehiscence Trial in Osijek (Bone augmentation with I-BCP, Bone augmentation with BX)
Completed
- Alveolar Ridge Enlargement
- +2 more
- Bone augmentation with I-BCP
- Bone augmentation with BX
-
Osijek, Osijek Baranja, CroatiaFaculty of Medicine Osijek
Aug 27, 2023
Cerebral Palsy Trial in New York, Portland (HABIT-ILE)
Recruiting
- Cerebral Palsy
- HABIT-ILE
-
New York, New York
- +1 more
Jun 10, 2022
Obese Trial in Lahore (Black Seed ( Nigella Sativa), Cumin Seed (Cuminum Cyminum))
Recruiting
- Obese
- Black Seed ( Nigella Sativa)
- Cumin Seed (Cuminum Cyminum)
-
Lahore, Punjab, PakistanSehat Medical Complex, Lahore
Mar 14, 2023
Toxicity of Blinatumomab in French ATU for Adult BCP-ALL R/R, or
Unknown status
- Acute Lymphoblastic Leukemia, in Relapse
- Acute Lymphoblastic Leukemia With Failed Remission
-
Paris, FranceCABANNES-HAMY Aurélie
Nov 20, 2018
ALL, MRD-positive, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Inotuzumab Ozogamicin)
Recruiting
- ALL
- +2 more
- Inotuzumab Ozogamicin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 14, 2023
Maxillary Sinus Disease Trial (Lateral sinus floor augmentation, Biphasic Calcium Phosphate, Injectable platlets rich fibrin)
Not yet recruiting
- Maxillary Sinus Disease
- Lateral sinus floor augmentation
- +2 more
- (no location specified)
Oct 6, 2023
IBD, Ulcerative Colitis, Crohn Disease Trial (Biologic Care Pathway)
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- Biologic Care Pathway
- (no location specified)
Sep 2, 2023
Carbapenem Resistant Klebsiella Pneumoniae Trial in Ratchathewi (Dose-adjustment by PKPD)
Recruiting
- Carbapenem Resistant Klebsiella Pneumoniae
- Dose-adjustment by PKPD
-
Ratchathewi, Bangkok, ThailandPhramongkutklao Hospital
May 7, 2023
Psoriasis Trial in Lahore (Apremilast 30mg)
Completed
- Psoriasis
- Apremilast 30mg
-
Lahore, Punjab, PakistanGhurki Hospital
Sep 5, 2023
International Leukemia Target Board
Not yet recruiting
- Relapsed Hematologic Malignancy
- Refractory Hematologic Malignancy
- Advice
- (no location specified)
Feb 25, 2022
Breast Cancer, Osteopenia Trial in Valencia (bone densitometry)
Recruiting
- Breast Cancer
- Osteopenia
- bone densitometry
-
Valencia, SpainHospital Clínico Universitario de Valencia
Mar 9, 2023
Breast Cancer, Quality of Life, Physical Activity Trial in Valencia (REBECCA system (smartwatch + mobile app use))
Not yet recruiting
- Breast Cancer
- +5 more
- REBECCA system (smartwatch + mobile app use)
-
Valencia, SpainHospital Clínico Universitario de Valencia
Aug 17, 2023
Cognitive Dysfunction, Postoperative Trial in Assiut (Lidocaine, Normal saline)
Recruiting
- Cognitive Dysfunction, Postoperative
- Lidocaine
- Normal saline
-
Assiut, Asyut, EgyptSeham Mohamed Moeen
Jan 7, 2021
Furcation Defects, Periodontal Diseases Trial in Oslo (Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane
Recruiting
- Furcation Defects
- Periodontal Diseases
- Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane)
- Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)
-
Oslo, NorwayInstitute of Clinical Dentistry, Faculty of Dentistry, Universit
May 19, 2022
Furcation Defects, Periodontal Diseases Trial in Oslo (Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane
Recruiting
- Furcation Defects
- Periodontal Diseases
- Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane)
- Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)
-
Oslo, NorwayInstitute of Clinical Dentistry, Faculty of Dentistry, Universit
May 19, 2022